Experienced guidance to optimize access planning and initiatives and build internal engagement.
- Developing access frameworks and tactical blueprints,
- Conducting internal access capacity building,
- Prioritizing countries and products,
- Mapping opportunities, and
- Conducting program feasibility studies to ensure the viability of the access programs
We create sustainable access strategies rooted in real market potential and supported by validated access indicators. We have proprietary scientific tools that help us understand and support patients better in the programs we manage.
- Patient affordability assessments,
- Affordability and willingness studies on physicians' willingness to prescribe and patients’ willingness and ability to pay,
- We also help develop business cases, and
- Offer stakeholder engagement strategies
Optimization of the Patient Support Programs (PSPs) and Patients Assistance Programs (PAPs) we manage are done by continuously evaluating program performance and outcomes. This includes,
- Conducting program strategic reviews,
- Gathering perspectives from patients and key opinion leaders, as well as stakeholder satisfaction surveys,
- Optimizing access programs’ impact based on Real-World Insights (RWI),
- Shaping the policies and blueprint for the access programs we manage, and
- Access to Medicines Index submission preparation
We systematically analyze program data to derive valuable insights aimed at enhancing patient access initiatives. This includes,
- Improving patient health and medical outcomes,
- Identify unmet needs,
- Optimizing the patient journey and experience,
- Informing clinical and policy healthcare decision-making,
- Refining access strategies, and
- Guiding healthcare system improvements